Clinical Trials

49 enrolled

Pancreatic Neoplasms, Colorectal Neoplasms

NCT07214298 2026-02-06

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

35 enrolled

Phase 1/2 Not yet recruiting

Pancreatic Neoplasms

NCT07377526 2026-01-30

Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

37 enrolled

Pancreatic Neoplasms

NCT07312422 2026-01-26

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study

10 enrolled

Pancreatic Neoplasms

NCT04146298 2025-12-24

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT07284277 2025-12-16

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

30 enrolled

Pancreatic Neoplasms

NCT02481635 2025-12-08

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

30 enrolled

Pancreatic Neoplasms

NCT03767582 2025-12-03

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

46 enrolled

Pancreatic Neoplasms

NCT06782932 2025-12-03

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

38 enrolled

Adenocarcinoma, Carcinoma, Pancreatic Neoplasms

NCT05438459 2025-11-18

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

130 enrolled

Pancreatic Neoplasms, Stomach Neoplasms

NCT04821284 2025-11-04

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

120 enrolled

Pancreatic Neoplasms

NCT03192462 2025-10-29

TACTOPS

37 enrolled 13 charts

Pancreatic Neoplasms

NCT04954599 2025-10-07

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

126 enrolled

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT07153289 2025-09-03

ResCPa

Phase 1/2 Not yet recruiting

38 enrolled

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT04191421 2025-08-22

Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer

35 enrolled 10 charts

Pancreatic Neoplasms

NCT06758544 2025-08-17

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

18 enrolled

Pancreatic Neoplasms

NCT05057013 2025-08-11

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

81 enrolled

Lethal Congenital Contracture Syndrome 2, Fibromatosis, Gingival, 2, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Prostatic Neoplasms, Castration-Resistant, Triple Negative Breast Neoplasms

NCT01342354 2025-07-18

Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer

15 enrolled 13 charts

Pancreatic Neoplasms

NCT07066995 2025-07-15

BAH2573-102

60 enrolled

Pancreatic Neoplasms

NCT05944237 2025-06-08

HTL0039732 in Participants With Advanced Solid Tumours

EndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

150 enrolled

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05964361 2025-04-25

IL15-TransDC

GastrointestinalGynecologic

10 enrolled

Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT06483555 2025-04-16

PANGEA

DermatologicGastrointestinal

104 enrolled

Pancreatic Neoplasms, Neoplasms, Basal Cell

NCT04247165 2025-03-12

LAPTOP

55 enrolled

Pancreatic Neoplasms

NCT05927142 2025-02-25

DURIPANC

43 enrolled

Pancreatic Neoplasms

NCT06844422 2025-02-25

Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)

37 enrolled

Pancreatic Neoplasms

NCT06736717 2025-02-06

PANCONVA

21 enrolled

Pancreatic Neoplasms

NCT04662112 2025-01-28

NASOX

40 enrolled

Pancreatic Neoplasms

NCT03699319 2025-01-23

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

49 enrolled

Pancreatic Neoplasms

NCT06572813 2025-01-10

CISPD-7

63 enrolled

Pancreatic Neoplasms

NCT03368963 2025-01-07

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

64 enrolled

Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT06761027 2025-01-07

mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

29 enrolled

Pancreatic Neoplasms

NCT05218889 2024-12-31

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

90 enrolled

Pancreatic Neoplasms

NCT05121038 2024-12-17

CENDIFOX

50 enrolled

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms

NCT05610826 2024-10-26

Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver

Phase 1/2 Withdrawn

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT04098432 2024-09-23

CA209-9KH

15 enrolled

Pancreatic Neoplasms

NCT03269526 2024-09-19

BATs Treatment for Pancreatic Cancer, Phase Ib/II

22 enrolled

Pancreatic Neoplasms

NCT06380816 2024-08-20

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

BreastGastrointestinalGynecologicHead & NeckThoracic

167 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02024009 2024-07-25

SCALOP-2

159 enrolled

Phase 1/2 Not yet recruiting

Pancreatic Neoplasms

NCT06513455 2024-07-22

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

132 enrolled

Pancreatic Neoplasms

NCT06454448 2024-06-28

Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer

20 enrolled

Pancreatic Neoplasms

NCT05187338 2024-06-25

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

100 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT05832892 2024-06-14

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

Phase 1/2 Unknown

41 enrolled

Pancreatic Neoplasms

NCT06395337 2024-05-02

MIRCA & MIPAC

Phase 1/2 Unknown

20 enrolled